173 related articles for article (PubMed ID: 30375631)
1. Multicolor nanobubbles for FRET/ultrasound dual-modal contrast imaging.
Zhang X; Liu R; Dai Z
Nanoscale; 2018 Nov; 10(43):20347-20353. PubMed ID: 30375631
[TBL] [Abstract][Full Text] [Related]
2. Novel DiR and SPIO nanoparticles embedded PEG-PLGA nanobubbles as a multimodalimaging contrast agent.
Luo B; Zhang H; Liu X; Rao R; Wu Y; Liu W
Biomed Mater Eng; 2015; 26 Suppl 1():S911-6. PubMed ID: 26406092
[TBL] [Abstract][Full Text] [Related]
3. Novel dual-mode nanobubbles as potential targeted contrast agents for female tumors exploration.
Yang H; Zhou T; Cai W; Yi X; Liu X; Wang Y; Zhang L; Duan Y
Tumour Biol; 2016 Oct; 37(10):14153-14163. PubMed ID: 27539728
[TBL] [Abstract][Full Text] [Related]
4. Cyanine 5.5 conjugated nanobubbles as a tumor selective contrast agent for dual ultrasound-fluorescence imaging in a mouse model.
Mai L; Yao A; Li J; Wei Q; Yuchi M; He X; Ding M; Zhou Q
PLoS One; 2013; 8(4):e61224. PubMed ID: 23637799
[TBL] [Abstract][Full Text] [Related]
5. Nanobubbles for enhanced ultrasound imaging of tumors.
Yin T; Wang P; Zheng R; Zheng B; Cheng D; Zhang X; Shuai X
Int J Nanomedicine; 2012; 7():895-904. PubMed ID: 22393289
[TBL] [Abstract][Full Text] [Related]
6. Bioluminescence Imaging of Inflammation in Vivo Based on Bioluminescence and Fluorescence Resonance Energy Transfer Using Nanobubble Ultrasound Contrast Agent.
Liu R; Tang J; Xu Y; Dai Z
ACS Nano; 2019 May; 13(5):5124-5132. PubMed ID: 31059237
[TBL] [Abstract][Full Text] [Related]
7. A high-performance imaging probe with NIR luminescence and synergistically enhanced T1-T2 relaxivity for in vivo hepatic tumor targeting and multimodal imaging.
Liu J; Li Z; Yang X; Liu W; Wang B; Zhu Y; Mu K; Zhu W
Chem Commun (Camb); 2015 Sep; 51(69):13369-72. PubMed ID: 26207340
[TBL] [Abstract][Full Text] [Related]
8. FA-NBs-IR780: Novel multifunctional nanobubbles as molecule-targeted ultrasound contrast agents for accurate diagnosis and photothermal therapy of cancer.
Shen Y; Lv W; Yang H; Cai W; Zhao P; Zhang L; Zhang J; Yuan L; Duan Y
Cancer Lett; 2019 Jul; 455():14-25. PubMed ID: 31018151
[TBL] [Abstract][Full Text] [Related]
9. Annexin V conjugated nanobubbles: A novel ultrasound contrast agent for in vivo assessment of the apoptotic response in cancer therapy.
Zhou T; Cai W; Yang H; Zhang H; Hao M; Yuan L; Liu J; Zhang L; Yang Y; Liu X; Deng J; Zhao P; Yang G; Duan Y
J Control Release; 2018 Apr; 276():113-124. PubMed ID: 29522835
[TBL] [Abstract][Full Text] [Related]
10. Fluorescent activatable gadofullerene nanoprobes as NIR-MR dual-modal in vivo imaging contrast agent.
Li C; Huang H; Cui R; Li J; Guo X; Yao H; Liu B; Xu B; Li Y; Liu S; Dong J; Xing G; Sun B
Colloids Surf B Biointerfaces; 2018 Nov; 171():159-166. PubMed ID: 30029098
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound-Based Molecular Imaging of Tumors with PTPmu Biomarker-Targeted Nanobubble Contrast Agents.
Johansen ML; Perera R; Abenojar E; Wang X; Vincent J; Exner AA; Brady-Kalnay SM
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671448
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of prostate cancer using anti-PSMA aptamer A10-3.2-oriented lipid nanobubbles.
Fan X; Guo Y; Wang L; Xiong X; Zhu L; Fang K
Int J Nanomedicine; 2016; 11():3939-50. PubMed ID: 27574424
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence resonance energy transfer mediated large Stokes shifting near-infrared fluorescent silica nanoparticles for in vivo small-animal imaging.
He X; Wang Y; Wang K; Chen M; Chen S
Anal Chem; 2012 Nov; 84(21):9056-64. PubMed ID: 23017033
[TBL] [Abstract][Full Text] [Related]
14. "Dual Lock-and-Key"-Controlled Nanoprobes for Ultrahigh Specific Fluorescence Imaging in the Second Near-Infrared Window.
Tang Y; Li Y; Hu X; Zhao H; Ji Y; Chen L; Hu W; Zhang W; Li X; Lu X; Huang W; Fan Q
Adv Mater; 2018 Aug; 30(31):e1801140. PubMed ID: 29920793
[TBL] [Abstract][Full Text] [Related]
15. Charge-reversal-functionalized PLGA nanobubbles as theranostic agents for ultrasonic-imaging-guided combination therapy.
Yang H; Shen X; Yan J; Xie X; Chen Z; Li T; Li S; Qin X; Wu C; Liu Y
Biomater Sci; 2018 Aug; 6(9):2426-2439. PubMed ID: 30040100
[TBL] [Abstract][Full Text] [Related]
16. Upconverting rare-earth nanoparticles with a paramagnetic lanthanide complex shell for upconversion fluorescent and magnetic resonance dual-modality imaging.
Wang Y; Ji L; Zhang B; Yin P; Qiu Y; Song D; Zhou J; Li Q
Nanotechnology; 2013 May; 24(17):175101. PubMed ID: 23558298
[TBL] [Abstract][Full Text] [Related]
17. The fabrication of novel nanobubble ultrasound contrast agent for potential tumor imaging.
Xing Z; Wang J; Ke H; Zhao B; Yue X; Dai Z; Liu J
Nanotechnology; 2010 Apr; 21(14):145607. PubMed ID: 20220227
[TBL] [Abstract][Full Text] [Related]
18. Development of a macromolecular dual-modality MR-optical imaging for sentinel lymph node mapping.
Melancon MP; Wang Y; Wen X; Bankson JA; Stephens LC; Jasser S; Gelovani JG; Myers JN; Li C
Invest Radiol; 2007 Aug; 42(8):569-78. PubMed ID: 17620940
[TBL] [Abstract][Full Text] [Related]
19. Quantum dots decorated gold nanorod as fluorescent-plasmonic dual-modal contrasts agent for cancer imaging.
Wu Q; Chen L; Huang L; Wang J; Liu J; Hu C; Han H
Biosens Bioelectron; 2015 Dec; 74():16-23. PubMed ID: 26093124
[TBL] [Abstract][Full Text] [Related]
20. MRI-visible liposome nanovehicles for potential tumor-targeted delivery of multimodal therapies.
Ren L; Chen S; Li H; Zhang Z; Ye C; Liu M; Zhou X
Nanoscale; 2015 Aug; 7(30):12843-50. PubMed ID: 26022345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
